# A Phase 1 Study of S-3304 in Patients With Solid Tumors

> **NCT00033215** · PHASE1 · COMPLETED · sponsor: **Shionogi** · enrollment: 32 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** S-3304

## Key facts

- **NCT ID:** NCT00033215
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2003-02-13
- **Final completion:** 2003-03-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00033215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00033215, "A Phase 1 Study of S-3304 in Patients With Solid Tumors". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00033215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*